Search - Université de Rennes Access content directly

Filter your results

25 Results
authFullName_s : Christophe Duvoux
Image document

R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

Charlotte Costentin , Federico Piñero , Helena Degroote , Andrea Notarpaolo , Ilka F Boin et al.
JHEP Reports Innovation in Hepatology, 2022, 4 (5), pp.100445. ⟨10.1016/j.jhepr.2022.100445⟩
Journal articles hal-03633748v2

Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.

Yvon Calmus , Christophe Duvoux , Georges Pageaux , Philippe Wolf , Lionel Rostaing et al.
Journal of Hepatology, 2012, 57 (3), pp.564-71. ⟨10.1016/j.jhep.2012.04.022⟩
Journal articles istex hal-00865405v1

Long term results of liver transplantation for Wilson's disease: experience in France

Olivier Guillaud , Jérôme Dumortier , Rodolphe Sobesky , Dominique Debray , Philippe Wolf et al.
Journal of Hepatology, 2014, 60 (3), pp.579--589. ⟨10.1016/j.jhep.2013.10.025⟩
Journal articles hal-01068685v1

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

Alexandre Louvet , Julien Labreuche , Christophe Moreno , Claire Vanlemmens , Romain Moirand et al.
The Lancet Gastroenterology & Hepatology, 2022, 7 (5), pp.416-425. ⟨10.1016/S2468-1253(21)00430-1⟩
Journal articles hal-03594367v1
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Journal articles hal-01640061v1
Image document

Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial

Faouzi Saliba , Christophe Duvoux , Jean Gugenheim , Nassim Kamar , Sébastien Dharancy et al.
American Journal of Transplantation, 2017, 17 (7), pp.1843-1852. ⟨10.1111/ajt.14212⟩
Journal articles hal-01558819v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Journal articles hal-01395132v1
Image document

Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry

Hans-Christian Pommergaard , Andreas Arendtsen Rostved , René Adam Rasmussen , Mauro Salizzoni , Miguel Angel Gómez Bravo et al.
Liver Cancer, 2020, 9 (4), pp.455-467. ⟨10.1159/000507397⟩
Journal articles hal-02959943v1

Impact of the New MELD-based Allocation System on Waiting List and Post-Transplant Survival - A Cohort Analysis Using the French National CRISTAL Database

Carine Jasseron , Claire Francoz , Corinne Antoine , Camille Legeai , François Durand et al.
Transplant International, 2019, 32 (10), pp.1061--1073. ⟨10.1111/tri.13448⟩
Journal articles hal-02862291v1
Image document

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

François Villeret , Sébastien Dharancy , Domitille Erard , Armand Abergel , Louise Barbier et al.
JHEP Reports Innovation in Hepatology, 2023, 5 (3), pp.100668. ⟨10.1016/j.jhepr.2022.100668⟩
Journal articles hal-04020048v1

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1
Image document

Locoregional treatments before liver transplantation for hepatocellular carcinoma a study from the European Liver Transplant Registry

Hans-Christian Pommergaard , Andreas Arendtsen Rostved , René Adam , Lau Caspar Thygesen , Mauro Salizzoni et al.
Transplant International, 2018, 31 (5), pp.531-539. ⟨10.1111/tri.13123⟩
Journal articles hal-01771622v1

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort

Aurélie Barrail-Tran , Lauriane Goldwirt , Thibaut Gelé , Claire Laforest , Audrey Lavenu et al.
European Journal of Clinical Pharmacology, 2019, 75 (11), pp.1555-1563. ⟨10.1007/s00228-019-02725-x⟩
Journal articles hal-02280498v1
Image document

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

Helena Degroote , Federico Piñero , Charlotte Costentin , Andrea Notarpaolo , Ilka F Boin et al.
JHEP Reports Innovation in Hepatology, 2021, 3 (5), pp.100331. ⟨10.1016/j.jhepr.2021.100331⟩
Journal articles hal-03378783v2
Image document

Microsporidiosis after liver transplantation: A French nationwide retrospective study

Jérôme Dumortier , Sylvie Radenne , Nassim Kamar , Filomena Conti , Armand Abergel et al.
Transplant Infectious Disease, 2021, pp.e13665. ⟨10.1111/tid.13665⟩
Journal articles hal-03280899v1

Socioeconomic Deprivation Does Not Impact Liver Transplantation Outcome for HCC: A Survival Analysis From a National Database

Benjamin Menahem , Olivier Dejardin , Arnaud Alves , Ludivine Launay , Jean Lubrano et al.
Transplantation, 2021, 105 (5), pp.1061-1068. ⟨10.1097/TP.0000000000003340⟩
Journal articles hal-03244842v1

EARLY LIVER TRANSPLANTATION FOR SEVERE ALCOHOLIC HEPATITIS NOT RESPONDING TO MEDICAL TREATMENT: RESULTS OF THE FRENCH-BELGIAN PROSPECTIVE STUDY QUICKTRANS

Alexandre Louvet , Julien Labreuche , Christophe Moreno , Claire Vanlemmens , Romain Moirand et al.
Hepatology, 2020, 72, pp.4A-5A
Journal articles hal-03036281v1

Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models

Charlotte Costentin , Giuliana Amaddeo , Thomas Decaens , Karim Boudjema , Philippe Bachellier et al.
Liver International, 2017, 37 (5), pp.717 - 726. ⟨10.1111/liv.13388⟩
Journal articles hal-01657280v1

Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.

Thomas Decaens , Françoise Roudot-Thoraval , Hanaa Badran , Philippe Wolf , François Durand et al.
Liver International, 2011, 31 (6), pp.792-801. ⟨10.1111/j.1478-3231.2010.02425.x⟩
Journal articles istex hal-00739491v1
Image document

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

Audrey Coilly , Jérôme Dumortier , Danielle Botta-Fridlund , Marianne Latournerie , Vincent Leroy et al.
PLoS ONE, 2015, 10 (9), pp.e0138091. ⟨10.1371/journal.pone.0138091⟩
Journal articles hal-01326372v1
Image document

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

Lucy Meunier , Mohamed Belkacemi , George Philippe Pageaux , Sylvie Radenne , Anaïs Vallet-Pichard et al.
Viruses, 2023, 15 (1), pp.137. ⟨10.3390/v15010137⟩
Journal articles hal-03980202v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles hal-01412958v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1

Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations

Audrey Coilly , Yvon Calmus , Faiza Chermak , Jérôme Dumortier , Christophe Duvoux et al.
Liver Transplantation, 2015, 21 (10), pp.1312--1321. ⟨10.1002/lt.24228⟩
Journal articles hal-01220633v1